ATE176482T1 - Asp-b28-insulinkristalle - Google Patents

Asp-b28-insulinkristalle

Info

Publication number
ATE176482T1
ATE176482T1 AT94918771T AT94918771T ATE176482T1 AT E176482 T1 ATE176482 T1 AT E176482T1 AT 94918771 T AT94918771 T AT 94918771T AT 94918771 T AT94918771 T AT 94918771T AT E176482 T1 ATE176482 T1 AT E176482T1
Authority
AT
Austria
Prior art keywords
asp
insulin crystals
crystals
insulin
protamine
Prior art date
Application number
AT94918771T
Other languages
English (en)
Inventor
Per Balschmidt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK93727A external-priority patent/DK72793D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE176482T1 publication Critical patent/ATE176482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94918771T 1993-06-21 1994-06-21 Asp-b28-insulinkristalle ATE176482T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93727A DK72793D0 (da) 1993-06-21 1993-06-21 Nyt produkt
US08/127,672 US5547930A (en) 1993-06-21 1993-09-28 AspB28 insulin crystals

Publications (1)

Publication Number Publication Date
ATE176482T1 true ATE176482T1 (de) 1999-02-15

Family

ID=26064536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918771T ATE176482T1 (de) 1993-06-21 1994-06-21 Asp-b28-insulinkristalle

Country Status (10)

Country Link
EP (1) EP0705275B1 (de)
JP (1) JP2837956B2 (de)
AT (1) ATE176482T1 (de)
AU (1) AU6995794A (de)
DE (4) DE10199011I2 (de)
DK (1) DK0705275T3 (de)
ES (1) ES2130428T3 (de)
GR (1) GR3030130T3 (de)
NL (3) NL300021I2 (de)
WO (1) WO1995000550A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
AU711428B2 (en) * 1994-06-16 1999-10-14 Eli Lilly And Company Monomeric insulin analog formulations
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
GB2327424B (en) * 1994-06-16 1999-03-31 Lilly Co Eli Monomeric insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
PL189964B1 (pl) * 1996-06-20 2005-10-31 Novo Nordisk As Wodny preparat insuliny, środek farmaceutyczny dopodawania pozajelitowego oraz sposób poprawiania chemicznej stabilności preparatów insuliny
WO1997048413A1 (en) * 1996-06-20 1997-12-24 Novo Nordisk A/S Insulin preparations containing carbohydrates
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
US5866538A (en) * 1996-06-20 1999-02-02 Novo Nordisk A/S Insulin preparations containing NaCl
BE1013507A5 (fr) * 1996-11-22 2002-03-05 Lilly Co Eli Formulations d'analogues de l'insuline.
EP0969860B1 (de) * 1997-03-20 2002-07-17 Novo Nordisk A/S Verfahren zur herstellung eines therapeutischen puders durch copräzipitation von insulin und einem absorptionsverstärker
CA2306877A1 (en) 1997-10-24 1999-05-06 Eli Lilly And Company Insoluble insulin compositions
CO4970787A1 (es) 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
US20010007853A1 (en) * 1998-01-08 2001-07-12 Dimarchi Richard Dennis Method for administering monomeric insulin analogs
EP1044016B1 (de) 1998-01-09 2005-03-16 Novo Nordisk A/S Stabilisierte insulin-zubereitungen
DE19825447A1 (de) * 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
WO2003031432A1 (en) 2001-10-12 2003-04-17 Novo Nordisk A/S Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
JP2006522746A (ja) 2003-04-11 2006-10-05 ノボ　ノルディスク　アクティーゼルスカブ 置換されたアミドの薬学的使用
KR101243648B1 (ko) 2003-11-20 2013-03-14 노보 노르디스크 에이/에스 제조 및 주사 장치용에 최적인 프로필렌 글리콜 함유펩티드 제제
EP2386554A1 (de) 2005-07-04 2011-11-16 High Point Pharmaceuticals, LLC Histamine H3 Rezeptor aktive Verbindungen
EP1910317B1 (de) 2005-07-20 2013-07-03 Eli Lilly And Company 1-amino-verbundene verbindungen
ES2393757T3 (es) 2005-11-17 2012-12-27 Eli Lilly & Company Antagonistas de receptor de glucagón, preparación y usos terapéuticos
JP5312054B2 (ja) 2006-03-15 2013-10-09 ノボ・ノルデイスク・エー／エス アミリンとインスリンの混合物
US8394842B2 (en) 2006-03-28 2013-03-12 High Point Pharmaceuticals, Llc Benzothiazoles having histamine H3 receptor activity
DK2049475T3 (da) 2006-04-24 2012-03-05 Lilly Co Eli Cyclohexyl-substituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroid dehydrogenase1
EP2079732B9 (de) 2006-05-29 2012-03-21 High Point Pharmaceuticals, LLC 3-(1,3-benyodioxol-5-yl)-6- (4-cyclopropylpiperazin-1-yl)-pyridazin, dessen salze und solvate und dessen verwendung als histamin-h3-rezeptorantagonist
WO2008145728A1 (en) 2007-06-01 2008-12-04 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
BRPI0812354A2 (pt) 2007-06-01 2015-01-27 Novo Nordisk As Composição farmacêutica não-aquosa.
MX344293B (es) 2008-10-17 2016-12-13 Sanofi Aventis Deutschland Combinacion de una insulina y un agonista de glp-1.
EA020496B1 (ru) 2008-11-21 2014-11-28 ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Производное адамантилбензамида, фармацевтическая композиция, включающая его, и его применение
BR112012011403B8 (pt) 2009-11-13 2021-05-25 Sanofi Aventis Deutschland composição farmacêutica líquida compreendendo um agonista glp-1 e metionina e uso da mesma
PT2498802E (pt) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina
RU2546520C2 (ru) 2010-08-30 2015-04-10 Санофи-Авентис Дойчланд Гмбх Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа
EP2670368A4 (de) 2011-02-03 2015-04-15 Pharmedica Ltd Neue im mund zersetzbare filme zur insulinverabreichung zwecks behandlung von diabetes
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
US9408893B2 (en) 2011-08-29 2016-08-09 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI641381B (zh) 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
CN105899190B (zh) * 2014-01-09 2022-06-14 赛诺菲 门冬胰岛素的稳定化药物制剂
WO2015104314A1 (en) 2014-01-09 2015-07-16 Sanofi Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
JP2020143105A (ja) * 2014-01-09 2020-09-10 サノフイＳａｎｏｆｉ インスリンアスパルトの安定化された医薬製剤
SG11201604708VA (en) 2014-01-09 2016-07-28 Sanofi Sa Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
LT3229828T (lt) 2014-12-12 2023-06-12 Sanofi-Aventis Deutschland Gmbh Insulino glargino/liksisenatido fiksuoto santykio kompozicija
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2017163159A1 (en) * 2016-03-21 2017-09-28 Wockhardt Limited Biphasic pharmaceutical composition of insulin human

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation

Also Published As

Publication number Publication date
DE122006000017I1 (de) 2006-06-29
NL300212I1 (nl) 2006-02-01
DE69416409T2 (de) 1999-09-16
NL300021I2 (nl) 2006-05-01
DE10199011I2 (de) 2004-10-14
JP2837956B2 (ja) 1998-12-16
JPH08511779A (ja) 1996-12-10
WO1995000550A1 (en) 1995-01-05
DE10199011I1 (de) 2001-04-12
ES2130428T3 (es) 1999-07-01
AU6995794A (en) 1995-01-17
EP0705275A1 (de) 1996-04-10
DE69416409D1 (de) 1999-03-18
GR3030130T3 (en) 1999-07-30
EP0705275B1 (de) 1999-02-03
DE122006000015I1 (de) 2006-06-29
NL300211I1 (nl) 2006-02-01
DK0705275T3 (da) 1999-09-20
NL300021I1 (nl) 2000-12-01

Similar Documents

Publication Publication Date Title
NL300212I1 (nl) ASP-B28 insulinekristallen.
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
WO2000030622A3 (de) Verwendung von dialkylfumaraten zur behandlung von host-versus-graft reaktionen und von autoimmunerkrankungen
EP1820862A3 (de) Medizinische Präparate zur Behandlung von Alpha-Galaktosidase-A-Mangel
AU672018B2 (en) Looped, hairpin ribozyme
NO931919L (no) Optisk aktivt 5h-pyrrolo(3,4-b)pyrazinderivat, dets fremstilling samt farmasoeytiske preparater inneholdende derivatet
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
HU9201254D0 (en) Rapamicine-carbamates and medical preparations containing them as active agents
DE59407457D1 (de) Blockierung der anlagerung von keimen an menschliche zellen
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
IT1274241B (it) Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
FI961938A (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
DE69013557D1 (de) An Liposome gekuppelte bioaktive Verbindungen und ihre Verwendung in pharmazeutischen Zubereitungen.
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
DE69724453D1 (de) Camptothecine analoga, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen
DK578589A (da) Farmaceutisk praeparat indeholdende labdanterpenoidderivater og pyrimido(6,1-a)isoquinolin-4-onderivater, dets fremstilling og anvendelse
AU1447892A (en) Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
CA2247998A1 (en) Fragments of cr1 and their use
IT9048026A0 (it) Preparato farmaceutico e/o cosmetico.
ITDP920008A0 (it) Ustion-guariflash/ prodotto terapeutico per ustioni e piaghe infette, abrasioni, irritazioni cutanee, escoriazioni, senza controindicazioni,per uso esterno. farmaco di nuovissima invenzione, inesistente in commercio, tanto in italia che all'estero.
Kieffer Cosmetic surgery of the aging face: social, psychological, and ethical implications
张建慧 My Bracelet
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.